SCHEMBL7365147

SCHEMBL7365147

O=[N+]([O-])c1cc(-c2cn3c(n2)sc2ccccc23)cc(O)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
TSHR P16473 1/20 0.42
RAB9A P51151 1/20 0.42
ATM Q13315 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
THRB P10828 1/20 0.41
RPS6KA3 P51812 2/20 0.41
ERN1 O75460 1/20 0.40
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
MET P08581 1/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11012268 0.89 MAPT (0.46) FLT3MAPTSMN1; SMN2LMNATP53
SCHEMBL11004327 0.78 CASP3 (0.53) MAPTSMN1; SMN2LMNATP53TSHR
SCHEMBL73916 0.78 MBD2 (0.58) FLT3MAPTSMN1; SMN2LMNATP53
Hydrochloric Acid SCHEMBL11010648 0.78 MAPT (0.49) FLT3MAPTSMN1; SMN2LMNATP53
SCHEMBL11011725 0.77 MAPT (0.51) FLT3MAPTSMN1; SMN2LMNATP53
SCHEMBL8728241 0.77 POLB (0.40) FLT3MAPTSMN1; SMN2LMNATP53
SCHEMBL11010261 0.77 THRB (0.49) FLT3MAPTSMN1; SMN2LMNATP53
SCHEMBL7367277 0.76 MET (0.40) FLT3MAPTSMN1; SMN2LMNATP53
SCHEMBL11012438 0.76 LMNA (0.50) FLT3MAPTSMN1; SMN2LMNATP53
SCHEMBL9837374 0.74 RAB9A (0.53) FLT3MAPTSMN1; SMN2LMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed